DLX6 and nasopharyngeal carcinoma: The 5-ethynyl-2′-deoxyuridine (EdU) assay (Figure 3C) subsequently demonstrated that reduced DLX6 expression significantly decreased the proliferative capacity of NPC cells in comparison to the control group.